FULC
Price
$8.69
Change
-$0.06 (-0.69%)
Updated
Oct 14 closing price
Capitalization
470.06M
28 days until earnings call
Intraday Buy/Sell Signals
ONCY
Price
$1.21
Change
+$0.04 (+3.42%)
Updated
Oct 14 closing price
Capitalization
121.5M
28 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

FULC vs ONCY

Header iconFULC vs ONCY Comparison
Open Charts FULC vs ONCYBanner chart's image
Fulcrum Therapeutics
Price$8.69
Change-$0.06 (-0.69%)
Volume$537.67K
Capitalization470.06M
Oncolytics Biotech
Price$1.21
Change+$0.04 (+3.42%)
Volume$640.14K
Capitalization121.5M
FULC vs ONCY Comparison Chart in %
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FULC vs. ONCY commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a Hold and ONCY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (FULC: $8.69 vs. ONCY: $1.21)
Brand notoriety: FULC and ONCY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 114% vs. ONCY: 60%
Market capitalization -- FULC: $470.06M vs. ONCY: $121.5M
FULC [@Biotechnology] is valued at $470.06M. ONCY’s [@Biotechnology] market capitalization is $121.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 1 FA rating(s) are green whileONCY’s FA Score has 0 green FA rating(s).

  • FULC’s FA Score: 1 green, 4 red.
  • ONCY’s FA Score: 0 green, 5 red.
According to our system of comparison, FULC is a better buy in the long-term than ONCY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 5 TA indicator(s) are bullish while ONCY’s TA Score has 3 bullish TA indicator(s).

  • FULC’s TA Score: 5 bullish, 4 bearish.
  • ONCY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, FULC is a better buy in the short-term than ONCY.

Price Growth

FULC (@Biotechnology) experienced а -5.95% price change this week, while ONCY (@Biotechnology) price change was -10.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Reported Earning Dates

FULC is expected to report earnings on Nov 12, 2025.

ONCY is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FULC($470M) has a higher market cap than ONCY($121M). FULC YTD gains are higher at: 84.894 vs. ONCY (32.414). ONCY has higher annual earnings (EBITDA): -30.65M vs. FULC (-81.28M). FULC has more cash in the bank: 214M vs. ONCY (14.6M). ONCY has less debt than FULC: ONCY (888K) vs FULC (7.57M). FULC (0) and ONCY (0) have equivalent revenues.
FULCONCYFULC / ONCY
Capitalization470M121M388%
EBITDA-81.28M-30.65M265%
Gain YTD84.89432.414262%
P/E RatioN/A12.78-
Revenue00-
Total Cash214M14.6M1,466%
Total Debt7.57M888K853%
FUNDAMENTALS RATINGS
FULC vs ONCY: Fundamental Ratings
FULC
ONCY
OUTLOOK RATING
1..100
2177
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
78
Overvalued
PROFIT vs RISK RATING
1..100
92100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
3638
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
350

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FULC's Valuation (23) in the null industry is somewhat better than the same rating for ONCY (78) in the Biotechnology industry. This means that FULC’s stock grew somewhat faster than ONCY’s over the last 12 months.

FULC's Profit vs Risk Rating (92) in the null industry is in the same range as ONCY (100) in the Biotechnology industry. This means that FULC’s stock grew similarly to ONCY’s over the last 12 months.

FULC's SMR Rating (97) in the null industry is in the same range as ONCY (100) in the Biotechnology industry. This means that FULC’s stock grew similarly to ONCY’s over the last 12 months.

FULC's Price Growth Rating (36) in the null industry is in the same range as ONCY (38) in the Biotechnology industry. This means that FULC’s stock grew similarly to ONCY’s over the last 12 months.

FULC's P/E Growth Rating (100) in the null industry is in the same range as ONCY (100) in the Biotechnology industry. This means that FULC’s stock grew similarly to ONCY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FULCONCY
RSI
ODDS (%)
Bearish Trend 8 days ago
75%
Bearish Trend 8 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
90%
Momentum
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 8 days ago
80%
MACD
ODDS (%)
N/A
Bearish Trend 8 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
87%
Bearish Trend 8 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 8 days ago
87%
Bullish Trend 8 days ago
73%
Advances
ODDS (%)
Bullish Trend 14 days ago
87%
Bullish Trend 17 days ago
75%
Declines
ODDS (%)
Bearish Trend about 1 month ago
85%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 8 days ago
90%
Aroon
ODDS (%)
Bullish Trend 8 days ago
87%
Bullish Trend 8 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGRSX9.810.08
+0.82%
Principal Global Real Estate Sec R6
SSCPX7.480.06
+0.81%
Saratoga Small Capitalization I
ATHDX31.320.05
+0.16%
American Century Heritage R6
DLQAX13.97-0.01
-0.07%
BNY Mellon Large Cap Equity A
VNSAX24.51-0.09
-0.37%
Natixis Vaughan Nelson Select A

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with TRDA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
-0.69%
TRDA - FULC
48%
Loosely correlated
+4.30%
BEAM - FULC
45%
Loosely correlated
+0.12%
ADPT - FULC
45%
Loosely correlated
+0.52%
OCUL - FULC
43%
Loosely correlated
-5.23%
IPSC - FULC
43%
Loosely correlated
+1.78%
More

ONCY and

Correlation & Price change

A.I.dvisor tells us that ONCY and RIGL have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ONCY and RIGL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONCY
1D Price
Change %
ONCY100%
+3.42%
RIGL - ONCY
33%
Poorly correlated
+2.05%
SRRK - ONCY
29%
Poorly correlated
-6.93%
LGVN - ONCY
28%
Poorly correlated
-0.01%
RXRX - ONCY
27%
Poorly correlated
+6.51%
FULC - ONCY
26%
Poorly correlated
-0.69%
More